Medi Caps Share Price

Medi Caps Corporate Action

CMP as on08-Aug-22 15:58

₹ 45.55
-0.4 -0.87%

Open

₹ 46.40

Turnover (lac)

₹ 2

Prev. Close

₹ 45.95

Day's Vol (shares)

₹ 28,491

Day's Range

₹ 44.30
₹ 47.00

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 26-Jul-2022 - -
MEDI-CAPS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2022 inter alia to consider and approve the following businesses along with other routine matters:- 1. To consider and approve the Standalone as well as Consolidated Un-Audited Financial Results of the Company for the quarter ended on 30th June 2022 along with the Limited Review Report thereon. 2. To consider the matters relating to the ensuing Annual General Meeting.
Board Meeting - 17-May-2022 - -
MEDI-CAPS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2022 inter alia to consider and approve 1. the Standalone as well as Consolidated Audited Financial Results of the Company for the quarter as well as year ended on 31st March 2022. 2. the Standalone and Consolidated Audited Financial Statements including the Balance Sheet as at 31st March 2022 and the Statement of Profit and Loss and Cash flow Statement of Changes in equity and notes thereon for the year ended 31st March 2022. 3.To take on record the Standalone and Consolidated Auditors Report along with modified/unmodified opinion on the Financial Results for the quarter as well as year ended 31st March 2022. 4. Any other matter with the permission of the chair
Board Meeting - 02-Feb-2022 - -
MEDI-CAPS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2022 inter alia to consider and approve the Standalone as well as Consolidated Un-audited Quarterly Financial Results of the Company for the quarter and nine months ended on 31st December 2021 along with Limited Review Report and any other matter with the permission of the chair. In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to submit the Un-audited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December, 2021 duly approved by the Board at its meeting held today i.e.10th February, 2022 along with Limited Review Report given by the Statutory Auditors of the Company, as required under the above said Regulations. You are requested to please take on record the aforesaid Results for your records and reference. (As Per BSE Announcement Dated on 10/02/2022)
Board Meeting - 01-Nov-2021 - -
Quarterly Results In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to submit the Un-audited Standalone and Consolidated Financial Results for the quarter as well as half year ended 30th September, 2021 duly approved by the Board at its meeting held today i.e.10th November, 2021 along with Limited Review Report given by the Statutory Auditors of the Company, as required under the above said Regulations. Further, pursuant to Regulation 33(3)(f) and (g) of the Listing Regulations, we have also enclosed Statements of Assets and Liabilities and the Statement of Cash flow in the prescribed format for the half year ended 30th September, 2021. Further, copy of Un-Audited Financial Statements shall also be submitted in XBRL mode within 24 hours from the conclusion of Board Meeting. You are requested to please take on record the aforesaid Unaudited Financial Results along with Limited review Report for your records and reference. (As per BSE Announcement Dated on 10/11/2021)
Board Meeting - 08-Oct-2021 - -
Pursuant to requirement of Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, authorization to the persons for the purpose of determining the materiality of event or information and for making the disclosure to the Stock Exchange as and when required.
Board Meeting - 03-Aug-2021 - -
MEDI-CAPS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2021 ,inter alia, to consider and approve Standalone as well as Consolidated Un-audited Quarterly Financial Results of the Company for the quarter ended 30th June, 2021 along with Limited Review Report thereon & to consider matters relating to the ensuing Annual General Meeting of the company We are pleased to inform that, Board of Directors at their meeting held on 12th August, 2021 has inter alia considered and approved the businesses apart from routine business as mentioned in the attachment. (As Per BSE Announcement dated on 12.08.2021) Pursuant to Regulation 30 read with Schedule III Part A(A) and in compliance of Regulation 47(1)(a) of SEBI (LODR) Regulations, 2015 regarding extract of Standalone and Consolidated Un-Audited Quarterly Financial Results for the quarter ended on 30th June, 2021 which was approved by the Board in their 03/2021-2022 Board Meeting held on Thursday, 12th August, 2021 at 3.00 P.M. at the Corporate Office of the Company situated at 201, Pushpratna Paradise 9/5 New Palasiya, Opposite UCO Bank Indore (M.P.) 452001. We herewith enclose the newspaper advertisement published on 13th August, 2021 in Free Press Journal English edition and Choutha Sansar Hindi edition. You are requested to please take on record our above said information for your reference and record. (As Per BSE Announcement dated on 13.08.2021) Pursuant to regulation 33(3)(d) of SEBI (LODR) Regulation, 2015, the Un-Audited Standalone and Consolidated Financial Result along with the Limited Review Report thereon by Statutory Auditors for the Quarter ended 30.06.2021 approved by the Audit committee & Board of Directors at their meeting held on 12.08.2021 was submitted within due course of time in the PDF Format. We hereby draw your attention towards the fact that due to typographical error, some figures were erroneously filled in the Consolidated Segment Wise Revenue, Results & Capital Employed for the quarter ended 30th June, 2021.We hereby refurnish the revised Consolidated Segment Wise Revenue, Results & Capital Employed for the quarter ended 30th June, 2021. You are requested to please take on record the aforesaid Revised Segment Financial Results for your records and reference. (As Per BSE Announcement Dated on 18.08.2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity